Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
This clinical trial focuses on building a multimodal digital assessment model for Myasthenia Gravis and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology [NA]
This clinical trial update describes the assessment of gait analysis parameters and upper-limb evaluation in adults with various neurologica…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Integrating Art Therapy and Adapted Physical Activity: Toward Improved Quality of Life in Patients With Myasthenia Gravis [NA]
This clinical trial investigates whether combining art therapy with adapted physical activity can improve quality of life for people with my…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis [Phase 1]
Phase 1 clinical trial to evaluate the safety and preliminary efficacy of SYS6020 CAR T-cells in patients with refractory generalized myasth…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Rituximab EfFicacy IN MyasthEnia Gravis (REFINE) [Phase 3]
A Phase 3 clinical trial named REFINE is evaluating the efficacy of rituximab for generalized myasthenia gravis and is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Markers of Favorable Response to Complement Inhibitors Therapy
A clinical trial focused on markers predicting favorable response to complement inhibitor therapy in generalized myasthenia gravis, currentl…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Efgartigimod in IVIG Dependent Myasthenia Gravis Patients [Phase 3]
Phase 3 trial of efgartigimod in intravenous immunoglobulin-dependent myasthenia gravis patients is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Vitaccess Real MG Registry
Vitaccess Ltd is recruiting for the Real MG Registry, a study designed to collect real-world data on myasthenia gravis.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy [Phase 1]
Phase 1 clinical trial investigating C-CAR168 for autoimmune diseases refractory to standard therapy is currently recruiting, covering SLE, …
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period. [NA]
This clinical trial update outlines a study evaluating whether assistive gait devices, following a training period, can reduce fall risk in …
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis [NA]
Clinical trial update notes Rituximab as a treatment option being studied for new-onset acetylcholine receptor antibody-positive myasthenia …
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod [Phase 4]
A Phase 4 clinical trial is evaluating efgartigimod for treatment of myasthenia gravis exacerbations or crisis and is currently recruiting a…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BAFF-R CAR-T cell therapy for refractory neuroimmune diseases is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases [Phase 1]
This Phase 1 study evaluates LCAR-AIO CAR-T cells for relapsed/refractory neurological autoimmune diseases, recruiting at a major Chinese me…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Application of Artificial Intelligence in Precision Medicine and Healthcare [NA]
Clinical trial update describing an AI-driven precision medicine study that is currently recruiting participants for Myasthenia Gravis.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
This clinical trial update describes a multicenter prospective cohort study in China to improve precision diagnosis for Myasthenia Gravis an…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update for UCAR T-cell therapy targeting CD19/BCMA in relapse/refractory autoimmune diseases. The study includes seve…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Serum Auto-Antibodies in Neurological Diseases
Clinical trial update describing an ongoing study on serum auto-antibodies in neurological diseases, with enrollment by invitation and inclu…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
Clinical trial registry update for the PRISMA pregnancy registry, collecting data on infants and maternal serum/milk analysis to assess expo…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis [NA]
Clinical trial evaluating the ME&MG digital solution for autonomous assessment of Myasthenia Gravis; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients. [NA]
A CHU Nice clinical trial is recruiting to evaluate anti-RACH antibodies and neurocognitive disorder in patients with Alzheimer's disease or…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Meningococcal Vaccination in Patients on Complement Inhibitors
This clinical trial update concerns meningococcal vaccination in patients treated with complement inhibitors. It includes patients with gene…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Blinatumomab for Treatment of Refractory Myasthenia Gravis [Phase 2, Phase 3]
This item reports a Phase 2/Phase 3 clinical trial evaluating blinatumomab for refractory myasthenia gravis, which is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis [NA]
Clinical trial evaluating the effectiveness of Bu Zhong YiQi Tang in patients with Myasthenia Gravis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Prevalence and Impact of Fatigue in Myasthenic Patients Followed At Clermont-Ferrand University Hospital - "My" Asthenia
This clinical trial assesses how common fatigue is and its impact on patients with myasthenia gravis at Clermont-Ferrand University Hospital…